Changes in practice patterns affecting in-hospital and post-discharge survival among ACS patients

BMC Health Services Research

Volumn 6, Issue , 2006, Pages

  Stommel, Manfred ^a   Olomu, Ade ^b   Holmes Rovner, Margaret ^b   Corser, William ^a   Gardiner, Joseph C ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ARTICLE; CLINICAL PRACTICE; COHORT ANALYSIS; COMMUNITY HOSPITAL; COMORBIDITY; DEMOGRAPHY; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MEDICAL RECORD; MORTALITY; PRACTICE GUIDELINE; STATISTICAL ANALYSIS; SURVIVAL; UNITED STATES; HOSPITAL PATIENT; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; SURVIVOR; SYNDROME; TRENDS;

HOSPITALIZATION; HUMANS; INPATIENTS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PATIENT DISCHARGE; PERIOPERATIVE CARE; PHYSICIAN'S PRACTICE PATTERNS; POSTOPERATIVE CARE; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVORS; SYNDROME;

EID: 33750613333     PISSN: 14726963     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-6-140     Document Type: Article

References (39)

1. Mehta RH, Montoye CK, Gallogly BA, Baker P, Blount A, Faul J, Roychoudhury C, Borzak S, Fox S, Franklin M, Freundl M, Kline-Rogers E, LaLonde T, Orza M, Parrish R, Satwicz M, Smith MJ, Sobotka P, Winston S, Riba AA, Eagle KA: Improving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) Initiative. JAMA 2002, 287:1269-76.
2. Eagle KA, Gallogly M, Mehta RH, Baker PL, Blount A, Freundl M, Orza MJ, Parrish R, Riba AL, Montoye CK: Taking the National Guideline for Care of Acute Myocardial Infarction to the Bedside. Jt Comm J Qual Improv 2002, 28:5-19.
3. Eagle KA, Kline-Rogers E, Goodman SG, Gurfinkel EP, Azevum A, Flather MD, Granger CB, Erickson S, White K, Steg PG: Adherence to evidence-based therapies after discharge for acute coronary syndromes: An ongoing prospective, observational study. Am J Med 2004, 117:73-81.
4. Watson RE, Stein AD, Dwamena FC, Kroll J, Mitra R, McIntosh BA, Vasilenko P, Holmes-Rovner MM, Chen Q, Kupersmith J: Do race and gender influence the use of invasive procedures? J Gen Intern Med 2001, 16:227-34.
5. Barber K, Stommel M, Kroll J, Holmes-Rovner MM, McIntosh BA: Cardiac rehabilitation for community-based patients with myocardial infarction: Factors predicting discharge recommendation and participation. J Clin Epi 2001, 54:1025-30.
6. Dwamena FC, El Tamimi H, Watson RE, Kroll J, Stein AD, McLane A, Holmes-Rovner MM, McIntosh BA, Kupersmith J: The use of angiotensin-converting enzyme inhibitors in patients with acute myocardial infarction in community hospitals. Michigan State University Inter-Institutional Collaborative Heart (MICH) Study Group. Clin Cardiol 2000, 23:341-6.
7. Census Bureau. County Population Datasets 2006 [http://www.census.gov/ popest/datasets.html].
8. Olomu AB, Watson RE, Siddiqi AE, Dwamena FC, McIntosh B, Vasilenko P, Kupersmith J, Holmes-Rovner MM: Changes in rates of beta-blocker use in community hospital patients with acute myocardial infarction. J Gen Intern Med 2004, 19:999-1004.
9. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validity. J Chron Dis 1987, 40:373-83.
10. Hosmer DW, Lemeshow S: Applied Survival Analysis: Regression Modeling of Time to Event Data. New York, NY: John Wi, Mark DBley & Sone, Inc; 2002.
11. Grambsch PM, Thernau TM: Proportional hazard tests and diagnostics based on weighted residuals. Biometrika 1994, 81:515-26.
12. Harrel FE, Lee KA, Mark DB: Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996, 15:361-87.
13. Centers for Disease Control and Prevention. Health, United States, 2005. Hyattsville, MD: DHHS; 2005.
14. Silvet H, Spencer F, Yarzebski J, Lessard D, Gore JM, Goldberg RJ: Communitywide trends in the use and outcomes associated with β-blockers in patients with acute myocardial infarction. Arch Intern Med 2003, 163:2175-83.
15. Cannon CP, Weintraub WS, Demopoulos LA, Robertson DH, Gormley GJ, Braunwald E: Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy. Thrombolysis In Myocardial Infarction. Am J Cardiol 1998, 82:731-6.
16. Anonymous: Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 2000, 35:1122-9.
17. Hueb W, Soares PR, Gersh BJ, Cesar LA, Luz PL, Puig LB, Martinez EM, Oliveira SA, Ramirez JA: The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol 2004, 43:1743-51.
18. Yan AT, Yan RT, Tan M, Eagle KA, Granger CB, Dabbous OH, Fitchett D, Grima E, Langer A, Goodman S: In-hospital Revascularization and One-Year Outcome of Acute Coronary Syndrome Patients Stratified by the GRACE Risk Score. Amer J Cardiol 2005, 96:913-6.
19. Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC: Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992, 327:248-54.
20. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B: Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1989, 1:175-9.
21. Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R: Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. Lancet 1992, 340:1421-5.
22. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JMO, Wun CC, Davis BR, Braunwald E: The Cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996, 335:1001-19.
23. Hennekens CH, Sacks FM, Tonkin A, Jukema JW, Byington RP, Pitt B, Berry DA, Berry SM, Ford NF, Walker AJ, Natarajan K, Sheng-Lin C, Fiodorek FT, Belder R: Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses. Arch Intern Med 2004, 164:40-4.
24. Johnson D, Jin Y, Quan H, Cujec B: Beta-blockers and angiotensin- converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada. J Am Coll Cardiol 2003, 42:1438-45.
25. Lappé JM, Muhlestein JB, Lappé DL, Badger RS, Bair TL, Brockman R, French TK, Hofmann LC, Horne BD, Kralick-Goldberg S, Nicponski N, Orton JA, Pearson RR, Renlund DG, Rimmasch H, Roberts C, Anderson JL: Improvements in 1-year cardiovascular clinical outcomes associated with hospital-based discharge medication program. Ann Intern Med 2004, 141:446-53.
26. Pilote L, Abrahamowicz M, Rodrigues E, Eisenberg MJ, Rahme E: Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: a class effect? Ann Intern Med 2004, 141:102-12.
27. Goldberg RJ, Gurwitz JH: Disseminating the results of clinical trials to community-based practitioners: is anyone listening? Am Heart L 1999, 137:4-7.
28. Bhatt DL, Topol EJ: Percutaneous coronary intervention for patients with prior bypass surgery: therapy in evolution. Am J Med 2000, 108:176-7.
29. Daneman N, Austin PC, Tu JV: Investigating the determinants of decreasing postmyocardial infarction mortality: an analysis of in-hospital data from 1992 and 1997. Can J Cardiol 2001, 17:771-6.
30. Rogers WJ, Canto JG, Lambrew CT, Tiefenbrunn AJ, Kinkaid B, Shoultz DA, Frederick PD, Every N: Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol 2000, 36:2056-63.
31. Borkon AM, Muehlebach GF, House J, Marso SP, Spertus JA: A comparison of the recovery of health status after percutaneous coronary intervention and coronary artery bypass. Ann Thorac Surg 2002, 74:1526-30.
32. Frilling B, Schiele R, Gitt AK, Zahn R, Schneider S, Glunz H-G, Gieseler U, Jagodzinski E, Senges J: Too little aspirin for secondary prevention after acute myocardial infarction in patients at high risk for cardiovascular events: results from the MITRA study. Am Heart J 2004, 148:306-11.
33. Ellerbeck EF, Jencks SF, Radford MJ, Kresowik TF, Carig AS, Gold JA, Krumholz HM, Vogel RA: Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project. JAMA 1995, 273:1509-14.
34. Mosca L, Linfante AH, Benjamin EJ, Berra K, Hayes SN, Walsh BW, Fabunmi RP, Kwan J, Mills T, Simpson SL: National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation 2005, 111:499-510.
35. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, Mautner B, Corbalan R, Radley D, Braunwald E: The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision-making. JAMA 2000, 284:835-42.
36. O'Connor GT, Quinton HB, Traven ND, Ramunno LD, Dodds TA, Marciniak TA, Wennberg JE: Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project. JAMA 1999, 281:627-33.
37. Guadagnoli E, Landrum MB, Normand SL, Ayanian JZ, Garg P, Hauptman PJ, Ryan TJ, McNeil BJ: Impact of underuse, overuse, and discretionary use on geographic variation in the use of coronary angiography after acute myocardial infarction. Med Care 2001, 39:446-58.
38. Lloyd-Jones DM, Camargo CA, Allen LA, Giugliano RP, O'Donnell CJ: Predictors of long-term mortality after hospitalization for primary unstable angina pectoris and non-ST-elevation myocardial infarction. Am J Cardiol 2003, 92:1155-9.
39. Gardner SC, Grunwald GK, Rumsfeld JS, Mackenzie T, Gao D, Perlin JB, McDonald G, Shroyer AL: Risk factors for intermediate-term survival after coronary artery bypass grafting. Ann Thorac Surg 2001, 72:2033-7.